Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses

Biochemical Pharmacology

Volumn 58, Issue 10, 1999, Pages 1539-1546

  Cromlish, Wanda A ^a   Payette, Paul ^a   Kennedy, Brian P ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Baculovirus; Inhibitor; p nitrophenyl phosphate; Pervanadate; Protein tyrosine phosphatase; Vanadate

Indexed keywords

PERVANADATE; PROTEIN TYROSINE PHOSPHATASE; VANADIC ACID;

ARTICLE; BACULOVIRUS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ASSAY; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY;

ANIMALS; ANTIGENS, CD45; BACULOVIRIDAE; BIOLOGICAL ASSAY; BLOTTING, WESTERN; GENETIC VECTORS; PROTEIN-TYROSINE-PHOSPHATASE; QUALITY CONTROL; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SPODOPTERA; TRANSFECTION;

EID: 0032880903     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00242-7     Document Type: Article

References (34)

1. Charbonneau H., Tonks N.K. 1002 protein phosphatases? Annu Rev Cell Biol. 8:1992;463-493.
2. Neel B.G., Tonks N.K. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 9:1997;193-204.
3. Zhang Z.Y. Protein-tyrosine phosphatases Biological function, structural characteristics and mechanism of catalysis . Crit Rev Biochem Mol Biol. 33:1998;1-52.
4. Trowbridge I.S., Ostergaard H.L., Johnson P. CD45 A leukocyte-specific member of the protein tyrosine phosphatase family . Biochim Biophys Acta. 1095:1991;46-56.
5. Cahir McFarland E.D., Hurley T.R., Pingel J.T., Sefton B.M., Shaw A., Thomas M.L. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci USA. 90:1993;1402-1406.
6. Lin J., Brown V.K., Justement L.B. Regulation of basal tyrosine phosphorylation of the B cell antigen receptor complex by the protein tyrosine phosphatase, CD45. J Immunol. 149:1992;3182-3190.
7. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.-C., Ramachandran C., Gresser M.J., Tremblay M.L., Kennedy B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 283:1999;1544-1548.
8. Cicirelli M.F., Tonk N.F., Diltz C.D., Weiel J.E., Fischer E.H., Krebs E.G. Microinjection of protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc Natl Acad Sci USA. 87:1990;5514-5518.
9. Ahmad F., Li P.M., Meyerovitch J., Goldstein B.J. Osmotic loading of neutralizing antibodies demonstrates a role of protein-tyrosine-phosphatase-1B in negative regulation of the insulin action pathway. J Biol Chem. 270:1995;20503-20508.
10. Seely B.L., Staubs P.A., Reichart D.R., Berham P., Milarski K.L., Salteil A.R., Kusari J., Olefsky J.M. Protein tyrosine phosphatase-1B interacts with the activated insulin receptor. Diabetes. 45:1996;1379-1385.
11. Burke T.R. Jr, Kole H.K., Roller P.P. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp. Biochem Biophys Res Commun. 204:1994;129-134.
12. Cromlish W., Kennedy B. Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays. Biochem Pharmacol. 52:1996;1777-1785.
13. Summers MD and Smith GE, A Manual for Methods for Baculovirus Vectors and Insect Culture Procedures (Bulletin No, 1555). Texas A & M University, Texas Agricultural Experiment Station, College Station, TX, 1987.
14. Huyer G., Lui S., Kelly J., Moffat J., Payette P., Kennedy B., Tsaprailus G., Gresser M.J., Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem. 272:1997;843-851.
15. Yanagi S., Sugawara H., Kurosaki M., Sabe H., Yamamura H., Kurosaki T. CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells. J Biol Chem. 271:1996;30487-30492.
16. Sheng Z., Charbonneau H. The baculovirus Autographa californica encodes a protein tyrosine phosphatase. J Biol Chem. 268:1993;4728-4733.
17. Frangioni J.V., Beahm P.H., Shifrin V., Jost C.A., Neel B.G. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell. 68:1992;545-560.
18. Tonks N.K., Diltz C.D., Fischer E.H. Characterization of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 263:1988;6731-6737.
19. McVicar D.W., Mason A.T., Bere E.W., Ortaldo J.R. Activation of peripheral large granular lymphocytes with the serine/threonine phosphatase inhibitor, okadaic acid. Eur J Immunol. 24:1994;165-170.
20. Fujiki H., Suganuma M. Tumor necrosis factor-α, a new tumor promoter, engendered by biochemical studies of okadaic acid. J Biochem (Tokyo). 115:1994;1-5.
21. A/GSK-3α in A431 cells. J Biol Chem. 269:1994;14341-14344.
22. Lee S.-R., Kwon K.-S., Kim S.-R., Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem. 273:1998;15366-15372.
23. 2 for platelet-derived growth factor signal transduction. Science. 270:1996;296-299.
24. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem. 272:1997;217-221.
25. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem. 265:1990;2896-2902.
26. Li J., Elberg G., Shechter Y. Phenylarsine oxide and vanadate Apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes . Biochim Biophys Acta. 1312:1996;223-230.
27. Swarup G., Cohen S., Garbers D.L. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun. 107:1982;1104-1109.
28. Heyliger C.E., Tahiliani A.G., McNeil J.H. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science. 227:1985;1474-1477.
29. Goldfine A.B., Simonson D.C., Folli F., Patti M.-E., Kahn C.R. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab. 80:1995;3311-3320.
30. Kadota S., Fantus I.G., Deragon G., Guyda H.J., Hersh B., Posner B.I. Peroxides of vanadium A novel and potent insulin-mimetic agent which activates the insulin receptor kinase . Biochem Biophys Res Commun. 147:1987;259-266.
31. Fantus I.G., Kadota S., Deragon G., Foster B., Posner B.I. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry. 28:1989;8864-8871.
32. Posner B.I., Faure R., Burgess J.W., Bevan A.P., Lachance D., Zhang-Sun G., Fantus I.G., Ng J.B., Hall D.A., Lum B.S., Shaver A. Peroxovanadium compounds A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics . J Biol Chem. 269:1994;4596-4604.
33. Bevan A.P., Drake P.G., Yale J.-F., Shaver A., Posner B.I. Peroxovanadium compounds Biological actions and mechanism of insulin-mimesis . Mol Cell Biochem. 153:1995;49-58.
34. Yale J.-F., Vigeant C., Nardolillo C., Chu Q., Yu J.-Z., Shaver A., Posner B.I. In vivo effects of peroxovanadium compounds in BB rats. Mol Cell Biochem. 153:1995;181-190.